Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-22-000731
Filing Date
2022-01-13
Accepted
2022-01-13 16:43:13
Documents
2
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 10832
2 mammenpoa1.txt EX-24 3916
  Complete submission text file 0001225208-22-000731.txt   16069
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
SIC: 2834 Pharmaceutical Preparations

Mailing Address THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Mammen Mathai (Reporting) CIK: 0001421050 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-03215 | Film No.: 22529483